These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
133 related articles for article (PubMed ID: 15816188)
1. Granulomatous lesion on a bitch's nipple caused by Leishmania infantum. Gómez-Ochoa P; Gascón M; Aceña MC; Miana-Mena FJ; Castillo JA Vet Rec; 2005 Mar; 156(12):389. PubMed ID: 15816188 [No Abstract] [Full Text] [Related]
2. In vitro susceptibility to pentavalent antimony in Leishmania infantum strains is not modified during in vitro or in vivo passages but is modified after host treatment with meglumine antimoniate. Carrió J; Portús M BMC Pharmacol; 2002 May; 2():11. PubMed ID: 12019027 [TBL] [Abstract][Full Text] [Related]
3. Hepatic fibropoiesis in dogs naturally infected with Leishmania (Leishmania) infantum treated with liposome-encapsulated meglumine antimoniate and allopurinol. Castro RS; de Amorim IFG; Pereira RA; Silva SM; Pinheiro LJ; Pinto AJW; Azevedo EG; Demicheli C; Caliari MMV; Mosser DM; Michalick MSM; Frezard FJG; Tafuri WL Vet Parasitol; 2018 Jan; 250():22-29. PubMed ID: 29329619 [TBL] [Abstract][Full Text] [Related]
4. Infectivity to Phlebotomus perniciosus of dogs naturally parasitized with Leishmania infantum after different treatments. Miró G; Gálvez R; Fraile C; Descalzo MA; Molina R Parasit Vectors; 2011 Apr; 4():52. PubMed ID: 21489241 [TBL] [Abstract][Full Text] [Related]
5. Effects of antimonial therapy for canine leishmaniasis on antibody titer. Amusategui I; Sainz A; Tesouro MA Ann N Y Acad Sci; 1998 Jun; 849():444-6. PubMed ID: 9668509 [No Abstract] [Full Text] [Related]
6. Leishmania infantum-specific IgG, IgG1 and IgG2 antibody responses in healthy and ill dogs from endemic areas. Evolution in the course of infection and after treatment. Solano-Gallego L; Riera C; Roura X; Iniesta L; Gallego M; Valladares JE; Fisa R; Castillejo S; Alberola J; Ferrer L; Arboix M; Portús M Vet Parasitol; 2001 Apr; 96(4):265-76. PubMed ID: 11267753 [TBL] [Abstract][Full Text] [Related]
7. Evolution of serum albumin/globulin ratio after antimonial therapy in canine leishmaniasis. Amusategui I; Sainz A; Tesouro MA Ann N Y Acad Sci; 1998 Jun; 849():447-9. PubMed ID: 9668510 [No Abstract] [Full Text] [Related]
8. Long-term follow-up of dogs with leishmaniosis treated with meglumine antimoniate plus allopurinol versus miltefosine plus allopurinol. Manna L; Corso R; Galiero G; Cerrone A; Muzj P; Gravino AE Parasit Vectors; 2015 May; 8():289. PubMed ID: 26017164 [TBL] [Abstract][Full Text] [Related]
9. Real-time PCR assay in Leishmania-infected dogs treated with meglumine antimoniate and allopurinol. Manna L; Reale S; Vitale F; Picillo E; Pavone LM; Gravino AE Vet J; 2008 Aug; 177(2):279-82. PubMed ID: 17553711 [TBL] [Abstract][Full Text] [Related]
10. Clinical efficacy of two different drug combinations for the treatment of canine leishmaniasis. Pennisi MG; Lo Giudice S; Masucci M; De Majo M; Reale S; Vitale F Vet Res Commun; 2008 Sep; 32 Suppl 1():S303-5. PubMed ID: 18683068 [No Abstract] [Full Text] [Related]
11. Therapeutic Efficacy of a Mixed Formulation of Conventional and PEGylated Liposomes Containing Meglumine Antimoniate, Combined with Allopurinol, in Dogs Naturally Infected with Leishmania infantum. Dos Santos CCP; Ramos GS; De Paula RC; Faria KF; Moreira POL; Pereira RA; Melo MN; Tafuri WL; Demicheli C; Ribeiro RR; Azevedo EG; Do Monte-Neto R; Da Silva SM; Frézard F Antimicrob Agents Chemother; 2020 Jun; 64(7):. PubMed ID: 32284386 [TBL] [Abstract][Full Text] [Related]
12. Variation of proteinuria in dogs with leishmaniasis treated with meglumine antimoniate and allopurinol: a retrospective study. Pierantozzi M; Roura X; Paltrinieri S; Poggi M; Zatelli A J Am Anim Hosp Assoc; 2013; 49(4):231-6. PubMed ID: 23690493 [TBL] [Abstract][Full Text] [Related]
13. Some remarks about the LeishVet directions for the treatment of canine leishmaniasis. Lamothe J Vet Parasitol; 2010 May; 169(3-4):416-7; author reply 418-20. PubMed ID: 20106598 [No Abstract] [Full Text] [Related]
14. First report of the use of meglumine antimoniate for treatment of canine leishmaniasis in a pregnant dog. Spada E; Proverbio D; Groppetti D; Perego R; Grieco V; Ferro E J Am Anim Hosp Assoc; 2011; 47(1):67-71. PubMed ID: 21164165 [TBL] [Abstract][Full Text] [Related]
15. Management of leishmanial osteolytic lesions in a hypothyroid dog by partial tarsal arthrodesis. Franch J; Pastor J; Torrent E; Lafuente P; Diaz-Bertrana MC; Munilla A; Durall I Vet Rec; 2004 Oct; 155(18):559-62. PubMed ID: 15559422 [TBL] [Abstract][Full Text] [Related]
16. Long term follow-up of dogs diagnosed with leishmaniosis (clinical stage II) and treated with meglumine antimoniate and allopurinol. Torres M; Bardagí M; Roura X; Zanna G; Ravera I; Ferrer L Vet J; 2011 Jun; 188(3):346-51. PubMed ID: 20594876 [TBL] [Abstract][Full Text] [Related]
17. Value of Western blotting in the clinical follow-up of canine leishmaniasis. Fernández-Pérez FJ; Méndez S; de la Fuente C; Cuquerella M; Gómez MT; Alunda JM J Vet Diagn Invest; 1999 Mar; 11(2):170-3. PubMed ID: 10098690 [TBL] [Abstract][Full Text] [Related]
18. Canine leishmaniasis chemotherapy: dog's clinical condition and risk of Leishmania transmission. João A; Pereira MA; Cortes S; Santos-Gomes GM J Vet Med A Physiol Pathol Clin Med; 2006 Dec; 53(10):540-5. PubMed ID: 17105576 [TBL] [Abstract][Full Text] [Related]
19. Decreased sensitivity to meglumine antimoniate (Glucantime) of Leishmania infantum isolated from dogs after several courses of drug treatment. Gramiccia M; Gradoni L; Orsini S Ann Trop Med Parasitol; 1992 Dec; 86(6):613-20. PubMed ID: 1304703 [TBL] [Abstract][Full Text] [Related]
20. Comparative efficacy of meglumine antimoniate and aminosidine sulphate, alone or in combination, in canine leishmaniasis. Oliva G; Gradoni L; Cortese L; Orsini S; Ciaramella P; Scalone A; de Luna R; Persechino A Ann Trop Med Parasitol; 1998 Mar; 92(2):165-71. PubMed ID: 9625912 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]